SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th a
SMi Reports: Dr Samareh Lajaunias, Director at Combioxin will be speaking at SMi's 22nd Annual Superbugs & Superdrugs Conference in London in March 2020
SMi Reports: the agenda and speaker overview of the upcoming SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view.
SMi Reports: Biotech Genentech, discoverers of a promising new antibiotic, are set to speak at this year’s Superbugs & Superdrugs Conference in London, UK on 18th - 19th M
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho